Showing results (531-540 of 869) with videos related to
Sort By:
Pageof 87
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2021
Stratification Tools for Disease-Modifying Trials in Prodromal SynucleinopathyDario Arnaldi, Pietro Mattioli, Francesco Famà, et al.EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracersMatteo Bauckneht, Selene Capitanio, Stefano Raffa, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosisEva M Strijbis, Eline Coerver, Jop Mostert, et al.Multiple Sclerosis and Related Disorders|May 27, 2015
Risk tolerance to MS therapies: Survey results from the NARCOMS registryRobert J Fox, Amber Salter, Joan M Alster, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2021
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trialBianca Weinstock-Guttman, Robert Bermel, Gary Cutter, et al.Neurology|February 29, 2020
Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United StatesAhmed Z Obeidat, Yasir N Jassam, Le H Hua, et al.British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.BMJ Neurology Open|June 3, 2021
Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitisBenjamin Greenberg, Patricia Plumb, Gary Cutter, et al.Pediatrics|October 21, 2009
Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 yearR Scott Watson, Gilles Clermont, John P Kinsella, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosisMarcus Koch, Jop Mostert, Eva M Strijbis, et al.Pageof 87